Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

ACB Stock May Be Unpredictable Now, but It’s Certain to Find Its Feet

ACB stock, like most cannabis stocks, is like a teenager. It's big enough to cause trouble, but not old enough to know what it doesn't know.

The 5 Best Small-Cap Stocks to Buy for the Rest of the Year

Small-cap stocks can see their share price jump on small revenue gains. Here are five small-cap stocks that are ready for a year-end increase.

Should Investors Have More Patience with Tilray Stock?

Opportunities abound for Tilray stock but the cannabis infrastructure still needs to be built out, along with more favorable legalization momentum. For now, TLRY is interesting, but it will require patience from investors.

Is the Future of GE Stock Blowing in the Wind?

Although General Electric stock has a tough hill to climb, the industrial giant’s wind turbine technology has serious potential.

IBM Stock Will Benefit from Low Investor Expectations

IBM stock has been rising in 2019, but investors still wonder if Big Blue can turn its acquisition of Red Hat into a revenue driver.